Neuberger Berman Group’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $16.7K | Hold |
|
|||||
|
2023
Q1 | $24.4K | Sell |
|
|||||
|
2022
Q4 | $15.4K | Hold |
|
|||||
|
2022
Q3 | $22K | Hold |
|
|||||
|
2022
Q2 | $18K | Hold |
|
|||||
|
2022
Q1 | $22K | Hold |
|
|||||
|
2021
Q4 | $28K | Hold |
|
|||||
|
2021
Q3 | $53K | Hold |
|
|||||
|
2021
Q2 | $44K | Hold |
|
|||||
|
2021
Q1 | $30K | Sell |
|
|||||
|
2020
Q4 | $41K | Sell |
|
|||||
|
2020
Q3 | $197K | Sell |
|
|||||
|
2020
Q2 | $243K | Hold |
|
|||||
|
2020
Q1 | $156K | Hold |
|
|||||
|
2019
Q4 | $227K | Hold |
|
|||||
|
2019
Q3 | $292K | Sell |
|
|||||
|
2019
Q2 | $342K | Hold |
|
|||||
|
2019
Q1 | $422K | Hold |
|
|||||
|
2018
Q4 | $283K | Hold |
|
|||||
|
2018
Q3 | $496K | Hold |
|
|||||
|
2018
Q2 | $525K | Hold |
|
|||||
|
2018
Q1 | $391K | Hold |
|
|||||
|
2017
Q4 | $276K | Hold |
|
|||||
|
2017
Q3 | $177K | Hold |
|
|||||
|
2017
Q2 | $203K | Sell |
|
|||||
|
2017
Q1 | $199K | Sell |
|
|||||
|
2016
Q4 | $91K | Hold |
|
|||||
|
2016
Q3 | $105K | Hold |
|
|||||
|
2016
Q2 | $136K | Hold |
|
|||||
|
2016
Q1 | $132K | Hold |
|
|||||
|
2015
Q4 | $152K | Sell |
|
|||||
|
2015
Q3 | $369K | Buy |
|
|||||
|
2015
Q2 | $422K | Sell |
|
|||||
|
2015
Q1 | $532K | Sell |
|
|||||
|
2014
Q4 | $560K | Sell |
|
|||||
|
2014
Q3 | $819K | Hold |
|
|||||
|
2014
Q2 | $2.25M | Buy |
|
|||||
|
2014
Q1 | $2.47M | Sell |
|
|||||
|
2013
Q4 | $1.69M | Sell |
|
|||||
|
2013
Q3 | $2.66M | Sell |
|
|||||
|
2013
Q2 | $1.16M | Buy |
|